FDA Adverse Event Injury Summary report: N

GORE EXCLUDER AAA ENDOPROSTHESIS

MDR report key: 1910372 · Received November 24, 2010

Report

Report Number
2953161-2010-00215
Event Type
Injury
Date Received
November 24, 2010
Date of Event
December 1, 2009
Report Date
November 24, 2010
Manufacturer
W.L. GORE & ASSOCIATES
Product Code
MIH
PMA / PMN Number
P020004
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
TX, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

A REVIEW OF THE MANUFACTURING PAPERWORK HAS BEEN CONDUCTED. THE REVIEW OF THE MANUFACTURING PAPERWORK VERIFIED THAT THIS LOT MET ALL PRE-RELEASE SPECIFICATIONS.

Description of Event or Problem · 1

ON (B)(6), 2007, THE PT WAS IMPLANTED WITH TWO GORE EXCLUDER AAA ENDOPROSTHESES TO TREAT AN ABDOMINAL AORTIC ANEURYSM. ON (B)(6), 2009, A COMPUTED TOMOGRAPHY REVEALED A PROXIMAL TYPE I ENDOLEAK. ON (B)(6), 2009, A F/U COMPUTED TOMOGRAPHY REVEALED A PERSISTENT PROXIMAL TYPE I ENDOLEAK. ON (B)(6), 2010, THE PT WAS IMPLANTED WITH A GORE EXCLUDER AAA ENDOPROSTHESIS AORTIC EXTENDER COMPONENT TO TREAT THE PROXIMAL TYPE I ENDOLEAK. THE ENDOLEAK WAS RESOLVED AND NO FURTHER COMPLICATIONS WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 GORE EXCLUDER AAA ENDOPROSTHESIS MIH / SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT MIH W.L. GORE & ASSOCIATES WLG425 05262025

Patients

Seq Age Sex Outcome Treatment
1 71 YR Hospitalization| R ALBUTEROL| PLAVIX| CALCIUM PLUS VITAMIN D| MAXZIDE| LISINOPRIL| MULTI-VITAMIN| CRESTOR| ASPIRIN| TOPROL| NIASPIN| CHLORPHENIRAMINE| SINGULAIR